NCT00133510View on ClinicalTrials.gov

Influenza Vaccine in Pediatric Transplant Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

September 30, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Trivalent Subviron Influenza vaccine (Fluzone)

Trial Locations (1)

10029

Mount Sinai Hospital, New York

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00133510 - Influenza Vaccine in Pediatric Transplant Subjects | Biotech Hunter | Biotech Hunter